A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF [mycophenolate mofetil] and Extended Release (XL) Tacrolimus /MMF in de Novo Kidney Transplant Recipients.
Phase of Trial: Phase III
Latest Information Update: 19 Dec 2015
At a glance
- Drugs Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 10 Jun 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 10 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2009 Actual patient number (73) added as reported by ClinicalTrials.gov.